Skip to:Content
|
Bottom
Biosimilars : design and analysis of follow-on biologics için kapak resmi
Başlık:
Biosimilars : design and analysis of follow-on biologics
Yazar:
Chow, Shein-Chung, 1955- author.
ISBN:
9781466579705
Fiziksel Tanımlama:
1 online resource : text file, PDF
Seri:
Chapman & Hall/CRC biostatistics series ; 60
Seri Başlığı:
Chapman & Hall/CRC biostatistics series ; 60
İçerik:
1. Introduction -- 2. Bioequivalence experience for small-molecule drug products -- 3. Regulatory requirements for assessing follow-on biologics -- 4. Criteria for similarity -- 5. Statistical methods for assessing average biosimilarity -- 6. General approach for assessing biosimilarity -- 7. Non-inferiority versus equivalence/similarity -- 8. Statistical test for biosimilarity in variability -- 9. Sample size for comparing variabilities -- 10. Impact of variability on biosimilarity limits for assessing follow-on biologics -- 11. Drug interchangeability -- 12. Issues on immunogenicity studies -- 13. CMC requirements for biological products -- 14. Test for comparability in manufacturing process -- 15. Stability analysis of biosimilar products -- 16. Assessing biosimilarity using biomarker data -- 17. Current issues in biosimilar studies.
Özet:
"This is the first book entirely devoted to the design and analysis for assessment of biosimilarity and drug interchangeability of biosimilars, and test for comparability in manufacturing processes of biologic products. It covers all of the statistical issues that may occur in biosimilar studies under various study designs at various stages of research and development of biologic products"-- Provided by publisher.

"Biologic drug products are therapeutic moieties that are manufactured using a living system or organism. These are important life-saving drug products for patients with unmet medical needs. They also comprise a growing segment in the pharmaceutical industry. In 2007, for instance, worldwide sales of biological products reached $94 billion US dollars, accounting for about 15% of the pharmaceutical industry's gross revenue. Meanwhile, many biological products face losing their patents in the next decade"-- Provided by publisher.
Ayırtma:
Kopya:

Rafta:*

Kütüphane
Materyal Türü
Demirbaş Numarası
Yer Numarası
Durumu/İade Tarihi
Materyal Ayırtma
Arıyor...
E-Kitap 287275-1001 ONLINE
Arıyor...

On Order

Go to:Top of Page